Table 1. Selected concurrent medical conditions and medical interventions for 51 persons with Candida auris infection, New York, USA, 2013–2017 .
| Characteristic | No. (%) persons |
|---|---|
| Concurrent condition | |
| Respiratory insufficiency requiring support | 33 (65) |
| Mechanical ventilation at time of diagnosis | 17 (33) |
| Neurologic disease* | 24 (47) |
| Diabetes | 18 (35) |
| Malignancies | 11 (22) |
| Colon cancer | 5 (10) |
| End-stage renal disease | 8 (16) |
| Hemodialysis | 7 (14) |
| Kidney transplant | 1 (2) |
| Decubitus ulcers | 10 (20) |
| Otitis with complications |
2 (4) |
| Medical interventions | |
| Hemodialysis | 7 (14) |
| Central venous catheter within 7 d before first positive culture for C. auris | 31 (61) |
| Gastrostomy tube at time of diagnosis | 27 (53) |
| Receipt of systemic antifungal medication within 90 d before first culture positive for C. auris | 25 (49) |
| Receipt of systemic antibiotics within 14 d before first culture positive for C. auris | 42 (82) |
*Includes seizure disorder (n = 8), cerebrovascular accident (n = 7), dementia (n = 4), anoxic brain injury (n = 3), spinal cord injury (n = 2), and 1 case each of Parkinson’s disease, multiple sclerosis, Huntington’s disease, Guillain-Barré syndrome, traumatic brain injury, pituitary tumor, and neuropathy.